Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Weekly intra-articular injections of bone morphogenetic protein-7 inhibits osteoarthritis progression.

Hayashi M, Muneta T, Ju YJ, Mochizuki T, Sekiya I.

Arthritis Res Ther. 2008;10(5):R118. doi: 10.1186/ar2521. Epub 2008 Sep 30.

2.

Radiographic evaluation of arthritis: degenerative joint disease and variations.

Jacobson JA, Girish G, Jiang Y, Sabb BJ.

Radiology. 2008 Sep;248(3):737-47. doi: 10.1148/radiol.2483062112. Review.

PMID:
18710973
3.

Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.

Rioja I, Hughes FJ, Sharp CH, Warnock LC, Montgomery DS, Akil M, Wilson AG, Binks MH, Dickson MC.

Arthritis Rheum. 2008 Aug;58(8):2257-67. doi: 10.1002/art.23667.

4.

Radiographic evaluation of arthritis: inflammatory conditions.

Jacobson JA, Girish G, Jiang Y, Resnick D.

Radiology. 2008 Aug;248(2):378-89. doi: 10.1148/radiol.2482062110. Review.

PMID:
18641245
5.

Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis.

Donahue KE, Gartlehner G, Jonas DE, Lux LJ, Thieda P, Jonas BL, Hansen RA, Morgan LC, Lohr KN.

Ann Intern Med. 2008 Jan 15;148(2):124-34. Epub 2007 Nov 19. Review.

PMID:
18025440
6.

The protective effect of OP-1 on articular cartilage in the development of osteoarthritis.

Badlani N, Inoue A, Healey R, Coutts R, Amiel D.

Osteoarthritis Cartilage. 2008 May;16(5):600-6. Epub 2007 Oct 31. Erratum in: Osteoarthritis Cartilage. 2009 Apr;17(4):556.

7.
8.

COMP acts as a catalyst in collagen fibrillogenesis.

Halász K, Kassner A, Mörgelin M, Heinegård D.

J Biol Chem. 2007 Oct 26;282(43):31166-73. Epub 2007 Aug 22.

9.

Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone.

Hulejová H, Baresová V, Klézl Z, Polanská M, Adam M, Senolt L.

Cytokine. 2007 Jun;38(3):151-6. Epub 2007 Aug 3.

PMID:
17689092
10.
11.

Interaction of cartilage oligomeric matrix protein/thrombospondin 5 with aggrecan.

Chen FH, Herndon ME, Patel N, Hecht JT, Tuan RS, Lawler J.

J Biol Chem. 2007 Aug 24;282(34):24591-8. Epub 2007 Jun 22.

12.

Diagnostic impact of contemporary biomarker assays for rheumatoid arthritis.

Nikolaisen C, Rekvig OP, Nossent HC.

Scand J Rheumatol. 2007 Mar-Apr;36(2):97-100.

PMID:
17476614
13.

Low serum level of COMP, a cartilage turnover marker, predicts rapid and high ACR70 response to adalimumab therapy in rheumatoid arthritis.

Morozzi G, Fabbroni M, Bellisai F, Cucini S, Simpatico A, Galeazzi M.

Clin Rheumatol. 2007 Aug;26(8):1335-8. Epub 2007 Feb 7.

PMID:
17285224
14.

Serum levels of cartilage oligomeric matrix protein (COMP) increase temporarily after physical exercise in patients with knee osteoarthritis.

Andersson ML, Thorstensson CA, Roos EM, Petersson IF, Heinegård D, Saxne T.

BMC Musculoskelet Disord. 2006 Dec 7;7:98.

15.

Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.

Matsui T, Shimada K, Ozawa N, Hayakawa H, Hagiwara F, Nakayama H, Sugii S, Ozawa Y, Tohma S.

J Rheumatol. 2006 Dec;33(12):2390-7. Epub 2006 Aug 15.

PMID:
16924694
16.

The role of anti-cyclic citrullinated peptide antibodies in predicting progression of palindromic rheumatism to rheumatoid arthritis.

Russell AS, Devani A, Maksymowych WP.

J Rheumatol. 2006 Jul;33(7):1240-2. Epub 2006 May 15.

PMID:
16724377
17.

Diurnal variation in serum levels of cartilage oligomeric matrix protein in patients with knee osteoarthritis or rheumatoid arthritis.

Andersson ML, Petersson IF, Karlsson KE, Jonsson EN, Månsson B, Heinegård D, Saxne T.

Ann Rheum Dis. 2006 Nov;65(11):1490-4. Epub 2006 May 17.

18.

Antibodies to viral citrullinated peptide in rheumatoid arthritis.

Anzilotti C, Merlini G, Pratesi F, Tommasi C, Chimenti D, Migliorini P.

J Rheumatol. 2006 Apr;33(4):647-51. Epub 2006 Mar 1.

PMID:
16511941
19.

Serum levels of cartilage oligomeric matrix protein (COMP): a rapid decrease in patients with active rheumatoid arthritis undergoing intravenous steroid treatment.

Skoumal M, Haberhauer G, Feyertag J, Kittl EM, Bauer K, Dunky A.

Rheumatol Int. 2006 Sep;26(11):1001-4. Epub 2006 Feb 17.

PMID:
16485108
20.

Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjogren's syndrome.

Sène D, Ghillani-Dalbin P, Limal N, Thibault V, van Boekel T, Piette JC, Cacoub P.

Ann Rheum Dis. 2006 Mar;65(3):394-7.

Supplemental Content

Support Center